Norovirus

>

Latest News

Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine
Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine

March 6th 2025

Phase 1b trial data demonstrated immune response, with 85% reduction in viral shedding and robust mucosal immunity in elderly adults.

Enhancing Air Quality and Controlling Infections on Cruise Ships
Enhancing Air Quality and Controlling Infections on Cruise Ships

February 3rd 2025

Human Milk Sugar Blocks Norovirus in Lab Models
Human Milk Sugar Blocks Norovirus in Lab Models

January 23rd 2025

Norovirus Oral Tablet Vaccine Enters Phase 1b Trials
Norovirus Oral Tablet Vaccine Enters Phase 1b Trials

May 12th 2021

Sporadic Pediatric Norovirus Cases May Predict Broader Outbreaks
Sporadic Pediatric Norovirus Cases May Predict Broader Outbreaks

December 18th 2020

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.